Publications by authors named "Romain Supiot"

Claim this Profile
C
Cost-Effectiveness of Empagliflozin (JARDIANCE) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial.
Harinala Groyer, Romain Supiot, Jean Tardu, Nicolas Virely, Marine Sivignon

Clin Drug Investig· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France.
Megane Caillon, Benoit Brethon, Chrissy van Beurden-Tan, Romain Supiot, Antoine Le Mezo

Pharmacoecon Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.
Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay

J Mark Access Health Policy· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.
Peter Buggisch, Karsten Wursthorn, Albrecht Stoehr, Petar K Atanasov, Romain Supiot

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis